Story · Medicine & Biotech
Finally, a Vaccine for Cancer
1 outlet · first reported by NYT Health on
Trial results for a melanoma vaccine by Merck and Moderna found that patients who received it after surgery to remove tumors were 42 percent less likely to have a recurrence or to die within two years. (NYT Health)
Coverage, in order
-
Finally, a Vaccine for CancerTrial results for a melanoma vaccine by Merck and Moderna found that patients who received it after surgery to remove tumors were 42 percent less likely to have a recurrence or to die within two years.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.